Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intersect ENT, Inc. - Common Stock (NQ:XENT)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Intersect ENT, Inc. - Common Stock

< Previous 1 2 Next >
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization
From Intersect ENT, Inc.
Via Business Wire
Intersect ENT Reports Third Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe
From Intersect ENT®, Inc.
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, LMRK, XENT, JAX; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ: INOV)... 
From Halper Sadeh LLP
Via AccessWire
Topics Fraud
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, GTS, XONE, XENT; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / September 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ:INOV)... 
From Halper Sadeh LLP
Via AccessWire
Topics Fraud
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, XENT, FFWM, RIVE; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / August 19, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cornerstone OnDemand, Inc. (NASDAQ:CSOD)... 
From Halper Sadeh LLP
Via AccessWire
Topics Fraud
INVESTIGATION: Halper Sadeh LLP Investigates NLOK, XENT, NWHM; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / August 12, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: NortonLifeLock Inc. (NASDAQ:NLOK) concerning... 
From Halper Sadeh LLP
Via AccessWire
Topics Fraud
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021
Upgrades According to Northland Capital Markets, the prior rating for Points International Ltd 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2021
Upgrades DA Davidson upgraded the previous rating for AAON Inc (NASDAQ: 
Via Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
INTERSECT ENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intersect ENT - XENT
From Kahn Swick & Foti, LLC
Via Business Wire
Why Intersect ENT Shot 12% Higher on Friday
It's official: A big peer is buying out the specialty medical device maker. 
Via The Motley Fool
Intersect ENT Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Intersect ENT, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – XENT
From Halper Sadeh LLP
Via Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers SCWorx (NASDAQ:WORX) shares moved upwards by 20.59% to $3.08 during Friday's regular session. The current volume of 16.2 million shares is 348.19% of SCWorx... 
Via Benzinga
Medtronic Expands Its ENT Portfolio With Intersect ENT Acquisition For $28.25/Share
Medtronic plc (NYSE:MDT) 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Applied Molecular (NASDAQ:AMTI) shares increased by 19.38% to $35.54 during Friday's pre-market session. The market value of their outstanding shares is at $1.... 
Via Benzinga
Intersect ENT: Q2 Earnings Insights
Shares of Intersect ENT (NASDAQ:XENT) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 24.62% year over year to ($0... 
Via Benzinga
Intersect ENT Reports Second Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
U.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic Rhinosinusitis
From Intersect ENT
Via Business Wire
Earnings Scheduled For August 6, 2021
Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.... 
Via Benzinga
Intersect ENT Sees Q2 Sales Lag Wall Street Estimates; Raises $60M In Debt Funding
Intersect ENT Inc (NASDAQ: XENT) expects Q2 sales of approximately $27.3 million, slightly below the consensus estimate of $28.02 million. Record quarterly revenue from... 
Via Benzinga
Intersect ENT to Report Second Quarter 2021 Financial Results on August 6
From Intersect ENT, Inc.
Via Business Wire
Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan
From Intersect ENT, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021
Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE: 
Via Benzinga
Intersect ENT Insights: Return On Capital Employed
In Q1, Intersect ENT (NASDAQ:XENT) posted sales of $24.33 million. Earnings were up 7.66%, but Intersect ENT still reported an overall loss of $18.57 million. Intersect ENT... 
Via Benzinga
Intersect ENT Insights: Return On Capital Employed
In Q1, Intersect ENT (NASDAQ:XENT) posted sales of $24.33 million. Earnings were up 7.66%, but Intersect ENT still reported an overall loss of $18.57 million. In Q4, Intersect ENT... 
Via Benzinga
Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery
From Intersect ENT, Inc.
Via Business Wire
Recap: Intersect ENT Q1 Earnings
Shares of Intersect ENT (NASDAQ:XENT) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share rose 5.56% year over year to ($0.51),... 
Via Benzinga
Intersect ENT Reports First Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.